BioSpace News Archive

ProMIS Neurosciences Issues White Paper Entitled ‘State of the Art at AAIC 2018'

Key conference theme: targeting toxic amyloid-beta oligomers offers renewed hope for treatment of Alzheimer’s disease

July 31, 2018
·
4 min read
Business

Provention Bio Appoints Leading T1D Expert, Dr. Mark Rigby, as Vice President, Clinical Development

Provention strengthens its strategic platform in type 1 diabetes (T1D) interception and prevention

July 31, 2018
·
6 min read
Drug Development

Gynecologic Oncology Publishes Results of the INNOVATE Phase 2 Pilot Study Demonstrating Combination of Tumor Treating Fields with Paclitaxel May Improve Survival of Patients with Recurrent Ovarian Cancer

Progression free survival of patients treated with Tumor Treating Fields plus weekly paclitaxel was more than double that of weekly paclitaxel-treated historical controls.

July 31, 2018
·
5 min read
Pharm Country

Pharma reps and websites carry clout with physicians in Japan

Direct sales and digital content stand to give pharma an edge in this key global market, according to data from DRG Digital | Manhattan Research’s Taking the Pulse® Global 2018 study

July 31, 2018
·
4 min read
Business

Q2 2018 Performance Positions Sanofi for New Growth Phase

Q2 2018 Performance Positions Sanofi for New Growth Phase

July 31, 2018
·
9 min read
Drug Development

ReShape Lifesciences Announces European Trial to Support CE-Mark of ReShape Vest

ReShape Lifesciences Inc. announced the Company has commenced site initiation training for the first clinical trial site that will participate in the multi-center trial of the ReShape VestTM to support CE Mark approval.

July 31, 2018
·
5 min read
Biotech Bay

Second Genome Certified as Great Place to Work®

Second Genome, Inc. was certified as a great workplace last week by the independent analysts at Great Place to Work®.

July 31, 2018
·
3 min read
Policy

Rapid Medical Receives CE Mark Approval for TIGERTRIEVER 13

The TIGERTRIEVER 13 is the smallest profile stentriever, designed to safely retrieve clots from intracranial vessels of 1mm - 2.5mm.

July 31, 2018
·
2 min read
Business

Aldeyra Therapeutics Appoints Joshua Reed as Chief Financial Officer

Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), today announced the appointment of Joshua Reed as Chief Financial Officer.

July 31, 2018
·
6 min read
Policy

Eiger BioPharmaceuticals Announces Notice of Allowance for U.S. Patent Covering a Broad Range of Ritonavir-Boosted Lonafarnib Dosing Regimens for Treatment of Hepatitis Delta Virus Infection

Eiger BioPharmaceuticals, Inc. announced that it has received the Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. patent application number 15/335,327, entitled “Treatment of Hepatitis Delta Virus Infection.”

July 31, 2018
·
5 min read